Showing results (101-110 of 305) with videos related to
Sort By:
Pageof 31
Blood|February 5, 2008
Thalidomide for treatment of multiple myeloma: 10 years laterAntonio Palumbo, Thierry Facon, Pieter Sonneveld, et al.Cancer|October 26, 2012
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 studyMaria Teresa Petrucci, Anna Levi, Sara Bringhen, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2011
Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cellsBarbara Castella, Chiara Riganti, Francesca Fiore, et al.Cancers|July 2, 2021
Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLLCandida Vitale, Valentina Griggio, Chiara Riganti, et al.American Journal of Hematology|September 10, 2025
European Myeloma Network Consensus Statement on Functional High-Risk Multiple MyelomaSueh-Li Lim, Monika Engelhardt, Evangelos Terpos, et al.Intensive Care Medicine|June 10, 2010
Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancyVincenzo Squadrone, Massimo Massaia, Benedetto Bruno, et al.Annals of Hematology|February 11, 2010
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Ermanno Venturino, Roberto Passera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypesPaolo Corradini, Marco Ladetto, Francesco Zallio, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 15, 2022
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working groupAshutosh D Wechalekar, M Teresa Cibeira, Simon D Gibbs, et al.Clinical Lymphoma, Myeloma & Leukemia|December 20, 2011
How to manage neutropenia in multiple myelomaAntonio Palumbo, Jon Bladé, Mario Boccadoro, et al.Pageof 31